Development and Validation for Taiwan Version ID Pain Questionnaire (ID Pain-T) and DN4 Questionnaire.

NCT00599768 | Completed

• 2 other identifiers: A0081175TWN-2006-CNS-001
• Study Type: observational
• Target: 325
• Locations: 0 countries
• Sites: N/A

Brief Summary

This prospective cohort and multi-site study aims to develop Taiwan version (ID Pain-T) based on the original versions of ID Pain and also DN4, and validate both ID Pain-T and DN4 applied in Taiwanese subjects at the clinical setting.

Conditions

Neuralgia; Nerve Pain; Neuropathic Pain

Outcome Measures

Primary Outcomes (1)

• Determine the optimal cut-off score of ID Pain-T Questionnaire for screening of neuropathic pain

  end of study

Secondary Outcomes (2)

• Evaluate the predictive power of ID Pain-T Questionnaire for diagnosis of neuropathic pain

  end of study

• Develop and evaluate validity of a short form diagnostic tool based on DN4 structure

  end of study

Interventions

ID-Pain DN4 Questionnaire OTHER

This is a non-interventional questionnaire validation study

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

patients of non-headache pain for more than 30 days and those whose age is more than 18 years old

You may qualify if:

• Subjects without headache pain over 30 days and at least 18 years old who will visit the clinic, inclusive of male and female.
• Subjects who are able to complete the ID Pain-T Questionnaire.

You may not qualify if:

• Subjects who are illiterate or unable to complete questionnaire.
• Subjects who are currently participating in another study or have participated in another pain study within one month of study entry.
• Subjects with low back pain are unable to participate in this study; as the sciatica caused by the piriformis (exclusive of the other types of sciatic pain), lumbago, unclear identification in nerve injury (e.g. complex regional pain syndrome type I) or mixed origin (e.g. cancer pain).

Sponsors & Collaborators

• Pfizer's Upjohn has merged with Mylan to form Viatris Inc.: lead

Related Links

• To obtain contact information for a study center near you, click here.

MeSH Terms

Conditions

Neuralgia

Condition Hierarchy (Ancestors)

Peripheral Nervous System Diseases; Neuromuscular Diseases; Nervous System Diseases; Pain; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Officials

• Pfizer CT.gov Call Center

  Pfizer

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 11, 2008
• First Posted: January 24, 2008
• Study Start: March 1, 2008
• Primary Completion: December 1, 2008
• Study Completion: December 1, 2008
• Last Updated: January 22, 2021

Record last verified: 2009-11